ST Pharm Co.,Ltd. (237690.KQ)

KRW 84900.0

(-4.61%)

Revenue Summary of ST Pharm Co.,Ltd.

ST Pharm Co.,Ltd.'s latest annual revenue in 2023 was 284.99 Billion KRW , up 14.31% from previous year.
ST Pharm Co.,Ltd.'s latest quarterly revenue in 2024 Q2 was 44.58 Billion KRW , down -13.79% from previous quarter.
ST Pharm Co.,Ltd. reported a annual revenue of 249.32 Billion KRW in annual revenue 2022, up 50.52% from previous year.
ST Pharm Co.,Ltd. reported a annual revenue of 165.64 Billion KRW in annual revenue 2021, up 33.47% from previous year.
ST Pharm Co.,Ltd. reported a quarterly revenue of 44.58 Billion KRW for 2024 Q2, down -13.79% from previous quarter.
ST Pharm Co.,Ltd. reported a quarterly revenue of 61.2 Billion KRW for 2024 Q3, up 38.38% from previous quarter.

Annual Revenue Chart of ST Pharm Co.,Ltd. (2023 - 2015)

Historical Annual Revenue of ST Pharm Co.,Ltd. (2023 - 2015)

Year	Revenue	Revenue Growth
2023	284.99 Billion KRW	14.31%
2022	249.32 Billion KRW	50.52%
2021	165.64 Billion KRW	33.47%
2020	124.1 Billion KRW	33.08%
2019	93.25 Billion KRW	-4.59%
2018	97.73 Billion KRW	-51.81%
2017	202.8 Billion KRW	1.22%
2016	200.36 Billion KRW	45.13%
2015	138.05 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	51.72 Billion KRW	-57.12%
2024 Q2	44.58 Billion KRW	-13.79%
2024 Q3	61.2 Billion KRW	38.38%
2023 Q2	57.77 Billion KRW	14.08%
2023 Q3	55.94 Billion KRW	-3.16%
2023 Q4	120.62 Billion KRW	115.61%
2023 FY	284.99 Billion KRW	14.31%
2023 Q1	50.64 Billion KRW	-49.55%
2022 Q1	36.97 Billion KRW	-28.52%
2022 Q4	100.39 Billion KRW	65.06%
2022 FY	249.32 Billion KRW	50.52%
2022 Q3	60.82 Billion KRW	18.98%
2022 Q2	51.12 Billion KRW	38.25%
2021 Q4	51.73 Billion KRW	11.74%
2021 FY	165.64 Billion KRW	33.47%
2021 Q3	46.29 Billion KRW	14.72%
2021 Q2	40.35 Billion KRW	48.06%
2021 Q1	27.25 Billion KRW	-42.95%
2020 Q2	33.77 Billion KRW	67.48%
2020 Q3	22.38 Billion KRW	-33.73%
2020 Q4	47.78 Billion KRW	113.45%
2020 FY	124.1 Billion KRW	33.08%
2020 Q1	20.16 Billion KRW	-48.81%
2019 Q4	39.39 Billion KRW	96.53%
2019 Q2	18.12 Billion KRW	15.54%
2019 Q1	15.68 Billion KRW	-22.42%
2019 FY	93.25 Billion KRW	-4.59%
2019 Q3	20.04 Billion KRW	10.59%
2018 Q1	28.32 Billion KRW	-48.4%
2018 Q3	13.38 Billion KRW	-62.63%
2018 FY	97.73 Billion KRW	-51.81%
2018 Q2	35.81 Billion KRW	26.46%
2018 Q4	20.22 Billion KRW	51.13%
2017 Q4	54.88 Billion KRW	26.57%
2017 Q3	43.36 Billion KRW	-23.56%
2017 FY	202.8 Billion KRW	1.22%
2017 Q2	56.73 Billion KRW	18.64%
2017 Q1	47.82 Billion KRW	4.59%
2016 Q4	45.72 Billion KRW	-15.29%
2016 Q2	69.77 Billion KRW	125.86%
2016 FY	200.36 Billion KRW	45.13%
2016 Q1	30.89 Billion KRW	-29.95%
2016 Q3	53.97 Billion KRW	-22.64%
2015 Q3	45.73 Billion KRW	50.63%
2015 Q4	44.1 Billion KRW	-3.57%
2015 Q2	30.36 Billion KRW	0.0%
2015 FY	138.05 Billion KRW	0.0%

Peer Revenue Comparison of ST Pharm Co.,Ltd.

Name	Revenue	Revenue Difference
Sam Chun Dang Pharm. Co., Ltd	192.66 Billion KRW	-47.918%
Hyundai Bioscience Co., Ltd.	9.48 Billion KRW	-2905.802%
ABL Bio Inc.	65.54 Billion KRW	-334.789%
Cellid, Co., Ltd.	- KRW	-Infinity%